Rare diseases
Investigational molecules
Locations
Back to Poland45 clinical trials in Myslowice, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG
PolandA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
PolandA study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer
PolandComparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease
PolandComparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients
PolandStudy on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)
PolandStudy on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment
PolandLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
PolandStudy on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis
PolandStudy on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy
PolandStudy on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis
PolandStudy on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis, evaluating novel therapeutic approaches and treatments. Studies are examining the safety and efficacy of experimental medications for these chronic liver conditions.
Advanced clinical trials investigating treatments for Hepatocellular Carcinoma and Non-Muscle Invasive Bladder Cancer. Studies are evaluating combination therapies and immunotherapy approaches to improve patient outcomes.
Innovative research on Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis (NASH). Studies are exploring new combination therapies and investigating treatments for liver complications associated with metabolic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
